Risk of thromboembolic phenomena in patients with inflammatory bowel disease

被引:7
|
作者
Suarez Ferrer, Cristina [1 ]
Vera Mendoza, Maria Isabel [1 ]
Amo San Roman, Leticia [1 ]
Gonzalez Lama, Yago [1 ]
Calvo Moya, Marta [1 ]
Garcia Casas, Mercedes [1 ]
Abreu Garcia, Luis [1 ]
机构
[1] Hosp Univ Puerta de Hierro, Serv Gastroenterol & Hepatol, Madrid, Spain
来源
GASTROENTEROLOGIA Y HEPATOLOGIA | 2012年 / 35卷 / 09期
关键词
Thromboembolic phenomena; Inflammatory bowel disease; Risk of thrombosis; DEEP-VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; PULMONARY-EMBOLISM;
D O I
10.1016/j.gastrohep.2012.07.003
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Introduction: Inflammatory bowel disease (IBD) is an independent risk factor for thromboembolic phenomena (TEP). We evaluated the prevalence and the possible risk factors associated with developing TEP in patients with IBD in our center. Material and methods: Data were retrospectively collected from January 1995 to December 2011 from 23 patients. A total of 61% were diagnosed with Crohn's disease (CD) and 39% with ulcerative colitis (UC) according to routine criteria. Results: When the Montreal classification was used, 58% of the patients with CD had an inflammatory pattern (B1), 25% a stenosing pattern (B2) and 17% a fistulizing pattern (B3). Half the patients had ileocolic involvement (L3), one-third had colonic involvement (L2) and the remainder had Heal involvement (L1). Among patients with UC according to the Montreal classification, 78% had extensive colitis (E3), 11% had left colonic involvement (E2) and 11% had proctocolitis (El). During the event, almost half the patients with UC had severe inflammatory activity (S3; 44%), 33% had mild-moderate activity (51: 22%, S2: 11%) and only 22% were in remission (SO). Overall, at the time of the TEP, 48% of the patients had mild-moderate activity and 22% had severe activity. Likewise, 44% were hospitalized at the time of the event. In UC, an increase in the prevalence of TEP was found in admitted patients (66%). None of the patients had a family history of TER two patients (9%) had associated thrombophilia and 26% were active smokers. There were no TEP during pregnancy. Only one patient was taking contraceptive pills when the event occurred. The most frequent forms of TEP were deep vein thrombosis of the legs (55%) followed by pulmonary thromboembolism (25%). Conclusions: TEP are relatively frequent in patients with IBD, with a strong impact on morbidity and mortality. In our series, risk factors for these events were more extensive involvement (any of the groups) and severe inflammatory activity. No significant association between classical risk factors such as the use of contraceptives, pregnancy, coagulation disorders or smoking and the risk of TEP were found. (C) 2012 Elsevier Espana, S.L. and AEEH y AEG. All rights reserved.
引用
收藏
页码:634 / 639
页数:6
相关论文
共 50 条
  • [31] Frequency and risk factors for thromboembolic complications in patients with inflammatory bowel diseases
    Lishchinskaya, Albina A.
    Knyazev, Oleg, V
    Kagramanova, Anna, V
    Dudina, Galina A.
    Sabelnikova, Elena A.
    Li, Irina A.
    Noskova, Karina K.
    Bodunova, Natalia A.
    Parfenov, Asfold, I
    TERAPEVTICHESKII ARKHIV, 2022, 94 (02) : 172 - 179
  • [32] High rate of recurrent thromboembolic complications in patients with inflammatory bowel disease
    Seifert, C
    Prondzinski, MV
    Schneider, A
    Czwalinna, A
    Bleck, JS
    Wagner, S
    Ganser, A
    Manns, MP
    Goeke, MN
    GASTROENTEROLOGY, 2001, 120 (05) : A449 - A449
  • [33] THE ECONOMIC BURDEN OF THROMBOEMBOLIC EVENTS AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Yarur, Andres
    Mu, Fan
    Zichlin, Miriam L.
    Billmyer, Emma
    Downes, Nathaniel
    Yang, Hongbo
    Azimi, Nassir
    Setyawan, Juliana
    Strand, Vibeke
    GASTROENTEROLOGY, 2021, 160 (06) : S358 - S358
  • [34] The Increasing Incidence of Thromboembolic Events Among Patients with Inflammatory Bowel Disease
    Kuy, SreyRam
    Dua, Anahita
    Bhavin, Patel
    Seabrook, Gary R.
    Brown, Kellie R.
    Lewis, Brian
    Rossi, Peter J.
    Gosset, James
    Desai, Sapan
    Lee, Cheong J.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2013, 217 (03) : S161 - S161
  • [35] Clinical factors contributing to thromboembolic complications in patients with inflammatory bowel disease
    Arif, Murtaza
    Ananthakrishnan, Ashwin N.
    Beaulieu, Dawn B.
    Issa, Mazen
    Skaros, Susan
    Knox, Joshua F.
    Lemke, Kathryn
    Lundeen, Sarah J.
    Otterson, Mary F.
    Binion, David G.
    GASTROENTEROLOGY, 2008, 134 (04) : A350 - A350
  • [36] The risk of venous thromboembolic events in patients with inflammatory bowel disease: a systematic review and meta-analysis
    Arvanitakis, Konstantinos D.
    Arvanitaki, Alexandra D.
    Karkos, Christos D.
    Zintzaras, Elias A.
    Germanidis, Georgios S.
    ANNALS OF GASTROENTEROLOGY, 2021, 34 (05): : 680 - +
  • [37] Hypoalbuminemia as Risk Factor for Thromboembolic Events in Hospitalized Inflammatory Bowel Disease Patients: An Observational and Retrospective Analysis
    Marcello, Imbrizi
    Tirzah, Lopes
    Marlone, Cunha-Silva
    Daniela, Magro
    Paulo, Kotze
    Ciro, Montes
    Jazon, Almeida
    Virginia, Cabral
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S21 - S21
  • [38] Arterial thromboembolic complications of inflammatory bowel disease
    Porter, JA
    DISEASES OF THE COLON & RECTUM, 2005, 48 (12) : 2352 - 2352
  • [39] Arterial Thromboembolic Complications of Inflammatory Bowel Disease
    Hymel, Brett
    Kitzman, Geoffrey
    Victor, David
    Karlitz, Jordan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S354 - S354
  • [40] Risk of atherosclerosis in patients with inflammatory bowel disease
    Rebecca Doherty
    Nature Clinical Practice Gastroenterology & Hepatology, 2006, 3 (1): : 6 - 7